Lumateperone
Back to searchMolecule Structure
Scientific Name
Lumateperone
Description of the Drug
Lumateperone is a novel 2nd generation antipsychotic used to manage both positive and negative symptoms in patients with schizophrenia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06077
http://www.drugbank.ca/drugs/DB06077
Brand Name(s)
Not Available
Company Owner(s)
Intra-Cellular Therapies Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Serotonin transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL228 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL1468226 | |
DrugBank | DB06077 | |
PubChem: Thomson Pharma | 87220026 | |
PubChem | 21302490 | |
Nikkaji | J3.323.976I | |
PDBe | 92S | |
DrugCentral | 5358 | |
ChemicalBook | CB63032893 | |
rxnorm | LUMATEPERONE | LUMATEPERONE TOSYLATE |
ZINC | ZINC000116262036 |